DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation
Developing iPSC-Derived Liver Systems for MASLD Modeling and Therapy Screening
Opti-HEP: iPSC-derived Human Hepatocytes
Physiologically relevant liver disease models that can be generated at scale for disease modeling, assay development and screening applications.
+
Disease Modeling
DefiniGEN's platform technology enables the generation of predictive and phenotypically relevant iPSC-derived human disease models for a wide range of metabolic and liver diseases which can be produced at scale.
+
Profiling Molecules
Combine our expertise at generating iPSC-derived hepatocyte disease models with our wide panel of bespoke bioassays. We work as partners with your team to design and implement in-house screening of small molecules and advanced genetic therapies, so you can advance your program at speed.
+
Donor Variance Panel
DefiniGEN has a large panel of iPSC lines allowing us to offer all our disease models and cell-based bioassays in donors ranging in gender, age and ethnicity. Researchers use our donor panels to further screen their lead candidates and potentially inform the stratification of a successful clinical trial.
=
